Welcome to Oncology as a Nurse Practitioner!

Size: px
Start display at page:

Download "Welcome to Oncology as a Nurse Practitioner!"

Transcription

1 Welcome to Oncology as a Nurse Practitioner! As a nurse practitioner in cancer care there are many resources that can help orient you to the care of the patient and family with cancer. The members of the Oncology Nurse Practitioner Special Interest Group have developed an outline of resources for you that may help you do self study for cancer care. We encourage you to work with your local mentors and preceptors to apply this information to your particular cancer setting. There are some online and academic resources for which you may want to negotiate purchase or access that will help orient you to cancer care practice. Many academic centers will have these available to you. If these resources are available at your institution ask if you can be oriented and get the appropriate access to these applications, on line or personal access device resources. Some examples of these on line resources are: The Johns Hopkins POC_IT Antibiotic guide The Sanford Guide to Antimicrobials Up To Date Evocates If you have no experience at all in cancer, The Fundamentals of Cancer Course from the Oncology Nursing Society may be of benefit. You may want to inquire if the practice or health care administration of your setting will absorb the cost of the online course. ( Some books that may be helpful: 1. Washington Manual of Oncology: Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO (2007) 2. Cancer Symptom Management, Third Edition Yarbro,Frogge,Goodman (2004)

2 Some information overall that can be helpful to you I. Resources for information about cancer and specific information initial workup and treatment according to tumor and stage. i. i As you think about the patient with cancer you can be overwhelmed. It is better to think about the patient as having a specific cancer at a specific stage of cancer. This helps you narrow the focus of what you need to know for diagnosis, treatment and symptom management. II. Cancer diagnosis and staging When a patient presents to the cancer center, they generally have some workup completed that has indicated that they have cancer. The traditional history and physical and patient presentation used in general medicine is amended for the patient with cancer to include the pertinent diagnostic history and physical, radiology and pathology with pertinent markers A. Presenting the history for a new patient with cancer - 1. The "story" of the cancer workup and diagnosis thus far 2. Diagnostic Radiology - what radiology has been performed, results? i. sandprocedures/medicalim aging/medicalx-rays/ucm htm 3. Pathology - Specific factors (tumor size, lymph nodes) indicative of disease seriousness as per tumor i Companion Diagnostics - Specific to each tumor tumor markers for prognosis and prediction of response to therapy. i Metastatic work up - Specific to each tumor

3 6. Staging: Specific to each cancer i Other relevant components of the history III. Cancer treatment While the physician will usually decide the treatment for the specific cancer at one specific stage, it is important that the nurse practitioner understand the decision making and participation in the discussion of the implications of the treatment for the patient and family. These resources will outline the evidence based care for patients according to cancer type and stage. A. Discussion with patient and family regarding prognosis and treatment i. i iv B. Surgery C. Radiation D. Chemo/Biotherapy i. Writing Chemo Orders - chemoregimines.com E. Oral Therapies i. Adherence Issues ii Specific considerations E. Clinical Trials i. ncipoet.cancer.gov/docs/thebasics.ppt

4 IV. Symptom management during cancer treatment A. Review of systems for patients undergoing treatment You should ask - and the patient should respond to all of the following signs and symptoms the use of a symptom checklist using a 10 point scale for intensity is recommended so that symptom assessment can be done more easily and efficiently. Patients can complete these if they are able. The Oncology Nursing Society Putting Evidence into Practice (PEP) is an efficient way for you to apply assessment and intervention with an evidence base. There are many resources for patient education regarding symptom management. No matter what the resource, patients respond best to one on one counseling. i. Oncology Nursing Society: PEP Resources a. b.. National Cancer Institute The symptoms to be assessed can be amended to specific cancers and side effects of therapy of the individual patient. 1. Nausea 2. Vomiting 3. Pain 4. Fatigue 5. Neuropathy 6. Constipation 7. Diarrhea 8. Dyspnea 9. Mucositis 10. Dry Mouth 11. Myalgia 12. Hot flashes

5 13. Depression 14. Anxiety 15. Skin Rash 16. Overall cancer related distress B. Common Oncologic Emergencies - Recognition and Intervention I. C. Survivorship Issues I. Review of systems for patients in follow-up i Surveying for recurrence Specific follows up testing as per malignancy V. Metastatic Cancer A. Treatments I. People living with Cancer; plwc.org patient education B Indications of Disease Recurrence C. Symptom Assessment and Management with Metastatic Cancer I. D. Common Oncologic Emergencies - Recognition and Intervention E. End of Life Care 1. Pain Management I Symptoms specific to end of life care I.

6 VI. Communication A. Empathetic Communication B. Difficult conversations in cancer care 1. Breaking Bad News 2. Angry patients and families VII. Professional Issues A. Certification I B. Ongoing continuing education I. VIII. Specific Disease Information A. Breast Cancer Staging, prognostic and predictive factors and Treatment According to Stage a. Common Symptoms during Treatment b. Survivorship and Follow up Issues B. Lung Cancer Staging, prognostic and predictive factors and treatment according to stage I..

7 a. Common Symptoms during Treatment b. Survivorship and Follow up Issues C. Cool-Rectal Cancer Staging, prognostic and predictive factors and treatment according to stage Professional/page1 a. Common Symptoms during Treatment b. Survivorship and Follow up Issues D. Gynecologic/Ovarian Cancer A. Staging, prognostic and predictive factors and Treatment According to Stage Professional/page1 B. Common Symptoms during Treatment C. Survivorship and Follow up Issues E. Pancreatic Cancer A. Staging, prognostic and predictive factors and Treatment According to Stage Professional/page1 B. Common Symptoms during Treatment C. Survivorship and Follow up Issues F. GU Cancers - Prostate/Renal/Bladder Cancer A. Staging, prognostic and predictive factors and Treatment According to Stage

8 Professional/page1 B. Common Symptoms during Treatment C. Survivorship and Follow up Issues G. Non- Malignant /Malignant Hematology Evaluation A. Thrombocytopenia B. Neutrogena C. Anemia D. Bone marrow procedure - Checklists for procedure "sign off" i. Examples of procedure &playnext=1&videos =M7nNG2VdHuY

Palliative Care: Expanding the Role Throughout the Patient s Journey. Dr. Robert Sauls Regional Lead for Palliative Care

Palliative Care: Expanding the Role Throughout the Patient s Journey. Dr. Robert Sauls Regional Lead for Palliative Care Palliative Care: Expanding the Role Throughout the Patient s Journey Dr. Robert Sauls Regional Lead for Palliative Care 1 Faculty/Presenter Disclosure Faculty: Dr. Robert Sauls MD, with the Mississauga

More information

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords

2018 OCN Keywords January 22, 2018 Subject Area Weight Keywords Subject Area Weight Keywords Care Continuum 19% Care Continuum Coordination of Care Navigation Psychosocial Symptom Management Health Promotion/Screening and Early Detection Disease Prevention High-Risk

More information

Breast Cancer Treatment

Breast Cancer Treatment Breast Cancer Treatment Treatment 2 aspects 1. Treatment of the breast itself: Local Treatment 2. Treatment of the whole body = Systemic treatment Local Treatment Surgery +/- Radiation Usually: a. Breast

More information

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION ROTATION TITLE Outpatient Adult Oncology PURPOSE The outpatient oncology service will provide the PGY-2 resident with the opportunity to further develop and

More information

ILNA Points REFERENCE GUIDE

ILNA Points REFERENCE GUIDE Learn and Earn With ONS Nursing Education REFERENCE GUIDE Resources for AOCNP and AOCNS Renewal About ILNA The Individual Learning Needs Assessment (ILNA) method is the certification renewal process launched

More information

ILNA Points REFERENCE GUIDE

ILNA Points REFERENCE GUIDE Learn and Earn With ONS Nursing Education REFERENCE GUIDE Resources for CBCN Renewal About ILNA The Individual Learning Needs Assessment (ILNA) method is the certification renewal process launched in 2016

More information

Quality of Life and Survivorship:

Quality of Life and Survivorship: Quality of Life and Survivorship: Implications for Future Ovarian Cancer Research and Care Lari Wenzel, PhD Professor of Medicine & Public Health Associate Director, Population Science and Cancer Control

More information

Objectives Primary Objective: Secondary Objectives For T4 a, b, c tumors:

Objectives Primary Objective: Secondary Objectives  For T4 a, b, c tumors: Z1031 A randomized phase III trial comparing 16 to 18 weeks of neoadjuvant exemestane (25mg daily), letrozole (2.5mg), or anastrozole (1mg) in postmenopausal women with clinical stage II and III estrogen

More information

2/6/ Allina Health System. Disclosure. Objectives

2/6/ Allina Health System. Disclosure. Objectives Survivorship Marketing Care for Update Breast Cancer Patients November February 26, 62013 th, 2016 Sarah Jax, MA, APRN, AOCNP Minnesota Oncology Disclosure There are no conflicts of interest or relevant

More information

For more information, call AstraZeneca Access 360 at ASK-A360, Monday through Friday, 8:00 AM to 8:00 PM ET.

For more information, call AstraZeneca Access 360 at ASK-A360, Monday through Friday, 8:00 AM to 8:00 PM ET. 1-844-ASK-A360 1-844-275-2360 1-844-FAX-A360 1-844-329-2360 www.myaccess360.com For more information, call AstraZeneca Access 360 at 1-844-ASK-A360, Monday through Friday, 8:00 AM to 8:00 PM ET. Indications

More information

Integrative Medicine at SCCA: A New Program for Survivors

Integrative Medicine at SCCA: A New Program for Survivors Integrative Medicine at SCCA: A New Program for Survivors Heather Greenlee, ND, PhD Medical Director, Integrative Medicine Program Associate Member, Fred Hutch Associate Professor, UW School of Medicine

More information

Temozolomide Chemotherapy -

Temozolomide Chemotherapy - n The Leeds Teaching Hospitals NHS Trust Temozolomide Chemotherapy - instructions for taking during your radiotherapy for a primary brain tumour Information for patients This information is for patients

More information

WARNING, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS,

WARNING, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS, Celgene Corporation 86 Morris Avenue Summit, New Jersey 07901 Tel 908-673-9000 Fax 908-673-9001 October 2012 NEW Indication Announcement for ABRAXANE for Injectable Suspension (paclitaxel protein-bound

More information

Martha Trout on 6/17/2012 at Pleasant Valley Cancer Center. Jane Plummer. Tom Plummer

Martha Trout on 6/17/2012 at Pleasant Valley Cancer Center. Jane Plummer. Tom Plummer SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,

More information

Dr Ewan Hutchison UK Civil Aviation Authority. ICAO European Regional Civil Aviation Medicine Seminar/Workshop București November 2013

Dr Ewan Hutchison UK Civil Aviation Authority. ICAO European Regional Civil Aviation Medicine Seminar/Workshop București November 2013 Dr Ewan Hutchison UK Civil Aviation Authority ICAO European Regional Civil Aviation Medicine Seminar/Workshop București 11-15 November 2013 Types of Cancer Recertification after treatment Certification

More information

CAPhO Oncology Fundamentals Day Saturday, October 1, 2016

CAPhO Oncology Fundamentals Day Saturday, October 1, 2016 The Canadian Association of Pharmacy in Oncology Presents CAPhO Oncology Fundamentals Day www.capho.org #OFD16 www.acpho.org [Type here] Accreditation CAPhO Oncology Fundamentals Day is accredited by the

More information

Hospice and Palliative Medicine

Hospice and Palliative Medicine Hospice and Palliative Medicine Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the

More information

By: Tania Cortas, MD Arizona Oncology 03/10/2015

By: Tania Cortas, MD Arizona Oncology 03/10/2015 By: Tania Cortas, MD Arizona Oncology 03/10/2015 Epidemiology In the United States, CRC incidence rates have declined about 2 to 3 percent per year over the last 15 years Death rates from CRC have declined

More information

Metabolic Assessment Form

Metabolic Assessment Form Metabolic Assessment Form Approach Wellness and Aesthetics 200 Forsythe Street Fayetteville, NC 28303 Office: (910) 322-7368 Fax: (910) 483-5796 www.tawellness.net Name: Age: Sex: Date: Part 1: Please

More information

Hematology, Oncology & Blood & Marrow Transplant for NPs & PAs

Hematology, Oncology & Blood & Marrow Transplant for NPs & PAs PHARMACOLOGY CONTENT Hematology, Oncology & Blood & Marrow Transplant for NPs & PAs Select presentations will contain pharmacology content as noted in the program. Identified presentations represent approximately

More information

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult

More information

COA ADVANCED PRACTICE PROVIDER CALL

COA ADVANCED PRACTICE PROVIDER CALL COA ADVANCED PRACTICE PROVIDER CALL Tuesday, October 18 th, 12:30 pm ET 2015 Community Oncology Alliance 1 CAPP Co-Chairs: Sarah Alexander, NP-C, Lake Norman Oncology sarah@lakenormanoncology.com Diana

More information

MANAGING SIDE EFFECTS

MANAGING SIDE EFFECTS MANAGING SIDE EFFECTS 94 Managing Side Effects Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by Charles L. Loprinzi, MD The Mayo Clinic Rochester, Minnesota

More information

725 Jesse Jewell Pkwy, Suite 390 Gainesville, GA (770) (770) (facsimile)

725 Jesse Jewell Pkwy, Suite 390 Gainesville, GA (770) (770) (facsimile) Charles Nash, III, M.D., F.A.C.P. Richard J. LoCicero, M.D. Anup K. Lahiry, M.D. Timothy M. Carey, M.D. Andrew Johnson, M.D. 725 Jesse Jewell Pkwy, Suite 390 Gainesville, GA 30501 (770) 297-5700 (770)

More information

Palliative Care Management Diploma

Palliative Care Management Diploma Palliative Care Management Diploma Introduction Palliative care (WHO, 2002) is an approach that improves the quality of life of patients and their families facing the problems associated with lifethreatening

More information

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1 Caring for a Patient with Colorectal Cancer Tammy Triglianos RN, APRN-BC, AOCNP Nurse Practitioner, GI Oncology 10/15/2018 Objectives Describe common signs and symptoms of colorectal cancer Understand

More information

Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer

Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer 2006 ONS Congress Webcast Evaluation Form Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer Session length: 1 hour, 49 minutes Contact hours: 1.6 Pharmacology hours offered:

More information

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen). It is a very common cancer in men; some cancers grow very slowly,

More information

Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications

Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications 1 ONSQIR 1 Non-PRQS Measure Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications Performance Measure Name: Symptom Assessment 1-o1a Symptom Assessment

More information

Learn and Earn With ONS Nursing Education. ILNA Points REFERENCE GUIDE. Resources for CBCN Renewal.

Learn and Earn With ONS Nursing Education. ILNA Points REFERENCE GUIDE. Resources for CBCN Renewal. Learn and Earn With ONS Nursing Education REFERENCE GUIDE Resources for CBCN Renewal www.ons.org About The Individual Learning Needs Assessment () method is the certification renewal process that launched

More information

Cancer diagnosis and treatments- brief overview of the changing paradigm.

Cancer diagnosis and treatments- brief overview of the changing paradigm. Cancer diagnosis and treatments- brief overview of the changing paradigm. Pranshu Bansal MD New Mexico Cancer Center Identifying cancer in clinic Most common cancers are lung, breast, colon, prostate and

More information

Nutritional care during and after chemo- and radiotherapy. M. Larsson (SE)

Nutritional care during and after chemo- and radiotherapy. M. Larsson (SE) ESPEN Congress Leipzig 2013 Nursing Session Nutritional care during and after chemo- and radiotherapy M. Larsson (SE) Nutritional care during and after chemo- and radiotherapy Maria Larsson, RN, PhD Nurse

More information

Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA?

Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA? 17.6 FDA-Approved Patient Labeling Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) for Injection, for intravenous infusion only Read the Patient Information that comes with IXEMPRA

More information

My Cancer Portal y MCP Steering Group Jan 2016

My Cancer Portal y MCP Steering Group Jan 2016 My Cancer Portal Transforming Care After Treatment -TCAT Increased survivorship of patients with cancer Survivorship comes with a legacy Investment into detecting cancer early (DCE) Better treatments High

More information

Information. about cancer

Information. about cancer 1 Information about cancer This chapter may help you answer simple questions about what cancer is and how it is treated. There are more than 200 different types of cancer and a range of treatments. Being

More information

Gastrointestinal obstruction Dr Iain Lawrie

Gastrointestinal obstruction Dr Iain Lawrie Gastrointestinal obstruction Dr Iain Lawrie Consultant and Honorary Clinical Senior Lecturer in Palliative Medicine The Pennine Acute Hospitals NHS Trust / The University of Manchester iain.lawrie@pat.nhs.uk

More information

PATIENT PERSPECTIVES: Control of Symptoms and Side Effects of Metastatic Breast Cancer. Musa Mayer AdvancedBC.org

PATIENT PERSPECTIVES: Control of Symptoms and Side Effects of Metastatic Breast Cancer. Musa Mayer AdvancedBC.org PATIENT PERSPECTIVES: Control of Symptoms and Side Effects of Metastatic Breast Cancer Musa Mayer AdvancedBC.org THE GOAL AND THE CHALLENGE Goal: Maintaining best possible quality of life, while keeping

More information

Dear Mercy Cancer Center Radiation Oncology Patient

Dear Mercy Cancer Center Radiation Oncology Patient Dear Mercy Cancer Center Radiation Oncology Patient Welcome to our Department. In order to complete our records, and enable our physicians to ensure that your questions are fully addressed, we appreciate

More information

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology REVIEWED DATE / INITIALS Safety: Are you at risk for falls? Do you have a Pacemaker? Females; Is there a possibility you may be pregnant? Allergies: If YES, please list medication allergies: Do you have

More information

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology

PATIENT HEALTH QUESTIONNAIRE Radiation Oncology REVIEWED DATE / INITIALS Safety: Yes No Are you at risk for falls? Do you have a Pacemaker? Females; Is there a possibility you may be pregnant? Allergies: Yes No If YES, please list medication allergies:

More information

Guidelines for clinical placement in palliative care (Draft outline adapted from MPCU materials, APCA publications and FHSSA report )

Guidelines for clinical placement in palliative care (Draft outline adapted from MPCU materials, APCA publications and FHSSA report ) Guidelines for clinical placement in palliative care (Draft outline adapted from MPCU materials, APCA publications and FHSSA report ) 1. Introduction & Background 1.1. Strengthening and integrating palliative

More information

The Growing Landscape of Palliative Care

The Growing Landscape of Palliative Care The Growing Landscape of Palliative Care Jeannine M. Brant, PhD, APRN, AOCN, FAAN Scientist, Billings Clinic PI, Montana Cancer Consortium Assistant Affiliate Professor, Montana State University Health

More information

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018) Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018) I. Coordination of Care - 26% A. Breast health, screening, early detection, risk assessment and reduction 1. Issues related to

More information

Integrating Palliative and Oncology Care in Patients with Advanced Cancer

Integrating Palliative and Oncology Care in Patients with Advanced Cancer Integrating Palliative and Oncology Care in Patients with Advanced Cancer Jennifer Temel, MD Massachusetts General Hospital Cancer Center Director, Cancer Outcomes Research Overview 1. Why should we be

More information

Care of the Patient with Cancer

Care of the Patient with Cancer Chapter 17 Care of the Patient with Cancer 1 Slide 1 Slide 2 Oncology Branch of medicine that deals with the study of tumors Lung cancer is the leading cause of cancer-related related death in both men

More information

Supportive Care For Hematological Malignancies

Supportive Care For Hematological Malignancies Supportive Care For Hematological Malignancies Nawaf Alkhayat, MD Pediatric Hematology, Oncology & BMT Prince Sultan Military Medical City Riyadh, KSA Supportive care Definition Why we need supportive

More information

Drug Niraparib Olaparib

Drug Niraparib Olaparib Dear NCCN Value Pathway Committee, We are making this submission to provide information that we believe is relevant for developing NCCN Categories of Preference for the use of PARP inhibitors in recurrent

More information

patient decision aid advanced lung cancer

patient decision aid advanced lung cancer patient decision aid advanced lung cancer Introduction This aid is meant to supplement conversations with your care team. Patients who have used a decision aid like this said it helped them make care choices

More information

Standards Deficiency Resolution

Standards Deficiency Resolution Standards Deficiency Resolution If a deficiency or deficiencies are identified during the survey process, the center has 12 months from the date of survey to complete the deficiency resolution process.

More information

Survivorship: Life Beyond Cancer Treatment

Survivorship: Life Beyond Cancer Treatment Survivorship: Life Beyond Cancer Treatment 1 1 Dear Cancer Survivor, The Cancer Survivorship program at University of Maryland St. Joseph Medical Center s Cancer Institute is designed to help patients

More information

Health Industry Forum October 2, 2007 Scott Howell, MD Senior Director, Channel and Contracting Strategy Genentech

Health Industry Forum October 2, 2007 Scott Howell, MD Senior Director, Channel and Contracting Strategy Genentech 1 Cost Effectiveness & Pricing/Reimbursement A Biotech Case Study Health Industry Forum October 2, 2007 Scott Howell, MD Senior Director, Channel and Contracting Strategy Genentech Disclaimer 2 The views

More information

FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE NODE-POSITIVE BREAST CANCER

FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF HER2-POSITIVE NODE-POSITIVE BREAST CANCER NEWS RELEASE Media Contact: Kimberly Ocampo (650) 467-0679 Investor Contact: Sue Morris (650) 225-6523 Advocacy Contact: Ajanta Horan (650) 467-1741 FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF

More information

The Suffering in patients with Metastatic Breast Cancer

The Suffering in patients with Metastatic Breast Cancer The Suffering in patients with Metastatic Breast Cancer Jayoung Ahn, RN, MSN, KOAPN ASAN Medical Center Contents I. Background II. The suffering experienced by women with MBC Associated symptoms of metastasis

More information

Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis?

Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis? Impact of pre-treatment symptoms on survival after palliative radiotherapy An improved model to predict prognosis? Thomas André Ankill Kämpe 30.05.2016 MED 3950,-5 year thesis Profesjonsstudiet i medisin

More information

3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis

3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis Chapter 56 Care of the Patient with Cancer All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Cancer Rates in the US 1 in 2 men and 1 in 3 women

More information

NCCTG Status Report for Study N September 2007

NCCTG Status Report for Study N September 2007 Phase I/II Study of Concurrent Chemotherapy and Escalating Doses 3-D Conformal Radiotherapy (RT) Followed by Three Cycles of Chemotherapy for Unresectable Non-Small Cell Lung Cancer (NSCLC) Using a New

More information

Lipoplatin monotherapy for oncologists

Lipoplatin monotherapy for oncologists Lipoplatin monotherapy for oncologists Dr. George Stathopoulos demonstrated that Lipoplatin monotherapy against adenocarcinomas of the lung can have very high efficacy (38% partial response, 43% stable

More information

Establishing a Survivorship Program Within a Large Academic Medical Center

Establishing a Survivorship Program Within a Large Academic Medical Center Establishing a Survivorship Program Within a Large Academic Medical Center Andrew J. Ward FNP-BC Surgical Oncology, The University of Tennessee Medical Center Disclosures I have no disclosures. Program

More information

Nilotinib AEs (adverse events) in CML population:

Nilotinib AEs (adverse events) in CML population: Nilotinib AEs (adverse events) in CML population: The percentages below were taken from a randomized trial of nilotinib 300mg BID in newly diagnosed Ph+ CML patients (N=279) taken from the Tasigna 2017

More information

GASTRIC & PANCREATIC CANCER

GASTRIC & PANCREATIC CANCER GASTRIC & PANCREATIC CANCER ASCO HIGHLIGHTS 2005 Fadi Sami Farhat, MD Head of Hematology Oncology Division Hammoud Hospital University Medical Center Saida Lebanon Tel: +961 3 753 155 E-Mail: drfadi@drfadi.org

More information

CHEMOTHERAPY. What should I expect?

CHEMOTHERAPY. What should I expect? CHEMOTHERAPY What should I expect? WHAT IS CHEMOTHERAPY? Chemotherapy is treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemotherapy

More information

Managing Common Side Effects of MDS Treatment Cindy Murray NP Malignant Hematology Princess Margaret Cancer Centre

Managing Common Side Effects of MDS Treatment Cindy Murray NP Malignant Hematology Princess Margaret Cancer Centre Managing Common Side Effects of MDS Treatment Cindy Murray NP Malignant Hematology Princess Margaret Cancer Centre Choosing Treatment Recommendations Type of MDS How MDS is affecting you Availability of

More information

FDA Approves ABRAXANE for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer

FDA Approves ABRAXANE for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer October 12, 2012 FDA Approves ABRAXANE for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Approval Based on Significantly Improved Overall Response Rates in all Patients Regardless of

More information

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce

Author Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce Survey of disease and treatment-related t t related symptoms in outpatients with invasive i cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study, Abst # 9619) Michael J. Fisch,

More information

Who is at risk? What should we do in the clinic?

Who is at risk? What should we do in the clinic? Cognitive Changes after Cancer Treatment Patricia A. Ganz, M.D. Professor, UCLA Schools of Medicine & Public Health Director, UCLA-LIVESTRONG Survivorship Center of Excellence Jonsson Comprehensive Cancer

More information

Online/Self-study courses

Online/Self-study courses Online/Self-study courses This list of CE offerings is not all inclusive. ONCC accepts many other accredited CE programs for ILNA Points. If you would like to know the applicability of a program not listed,

More information

Celgene Receives Positive CHMP Opinion for ABRAXANE in Combination with Gemcitabine as Treatment for Patients with Metastatic Pancreatic Cancer

Celgene Receives Positive CHMP Opinion for ABRAXANE in Combination with Gemcitabine as Treatment for Patients with Metastatic Pancreatic Cancer November 22, 2013 Celgene Receives Positive CHMP Opinion for ABRAXANE in Combination with Gemcitabine as Treatment for Patients with Metastatic Pancreatic Cancer BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene

More information

4. Pertinent physical findings including: a. Results of tests performed on patient, including dates and specific findings:

4. Pertinent physical findings including: a. Results of tests performed on patient, including dates and specific findings: Medical Assessment Form Patient: SSN: Please answer each of the following questions about the patient. They concern the patient s claim of entitlement to disability benefits under the Social Security Act.

More information

New Patient Specialty Intake Form Department of Surgery

New Patient Specialty Intake Form Department of Surgery This form contains questions specific to the Department of Surgery. If you are new to Baylor College of Medicine and have not been seen in any of our offices, please be sure to complete our New Patient

More information

Communicating Title with Your Healthcare Team to Get the Care You Want. Click to edit Master text styles

Communicating Title with Your Healthcare Team to Get the Care You Want. Click to edit Master text styles Communicating Title with Your Healthcare Team to Get the Care You Want Click to edit Master text styles Lori Ranallo, Title RN, MSN, ARNP-BC, CBCN Click to edit Master text styles Breast Cancer Nurse Practitioner

More information

Case Scenario 1. Discharge Summary

Case Scenario 1. Discharge Summary Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal

More information

Drafting a Coverage Authorization Request Letter

Drafting a Coverage Authorization Request Letter Drafting a Coverage Authorization Request Letter The following information is presented for informational purposes only and is not intended to provide reimbursement or legal advice. Laws, regulations,

More information

Health Questionnaire

Health Questionnaire Patient Name Date of Birth Thank you for choosing Southern Cancer Center for your care. To help us best prepare for your appointment, please complete this form and bring it to your appointment. If you

More information

Sex and Sexuality During and After Cancer Treatment: Yes, there are things that help!

Sex and Sexuality During and After Cancer Treatment: Yes, there are things that help! Moving Beyond Cancer to Wellness Sex and Sexuality During and After Cancer Treatment: Yes, there are things that help! Leslie Vietmeier, RN, BSN, MN, FNP, ARNP-BC, SCCA Survivorship Clinic, FHCRC Survivorship

More information

1. What is fulvestrant?

1. What is fulvestrant? Talk to our breast care nurses 0808 800 6000 1. What is fulvestrant? 2. How does fulvestrant work? 3. When might fulvestrant be prescribed? 4. How is fulvestrant given? 5. How long will I be given fulvestrant

More information

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat. For the Patient: HNAVDOC Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck with docetaxel HN=Head and Neck AV=Advanced DOC=Docetaxel ABOUT THIS MEDICATION What are these drugs

More information

Oral Chemotherapy Nathan Brashear, PharmD Candidate 2017 University of Kentucky College of Pharmacy

Oral Chemotherapy Nathan Brashear, PharmD Candidate 2017 University of Kentucky College of Pharmacy Oral Chemotherapy Nathan Brashear, PharmD Candidate 2017 University of Kentucky College of Pharmacy 1 Objectives Identify the more commonly dispensed oral chemotherapy drugs and their indications/dosage

More information

SANTA MONICA BREAST CENTER INTAKE FORM

SANTA MONICA BREAST CENTER INTAKE FORM SANTA MONICA BREAST CENTER Who referred you to see us today? Who is your primary care physician? Are there any other MDs who you would like to receive today s visit information? No Yes MD contact info

More information

Managing Older Patients With Lymphoma and Multiple Myeloma

Managing Older Patients With Lymphoma and Multiple Myeloma 2006 ONS Congress Webcast Evaluation Form Managing Older Patients With Lymphoma and Multiple Myeloma Session length: 1 hour, 45 minutes Contact hours: 1.5 Pharmacology hours offered: 15 minutes How to

More information

Gynecologic Oncology Level: PGY-4

Gynecologic Oncology Level: PGY-4 Gynecologic Oncology Level: PGY-4 Service: Oncology Length of Rotation: 4 months Supervision: PGY-4 Resident Oncology Faculty All resident activity is directly supervised by the attending physician assigned

More information

STANDARDIZED PROCEDURE MANAGEMENT OF CHEMOTHERAPY (ADULT, PEDS)

STANDARDIZED PROCEDURE MANAGEMENT OF CHEMOTHERAPY (ADULT, PEDS) I. Definition Chemotherapy is the use of cytotoxic drugs, hormones, antihormones, and biologic agents to treat malignancies. Selection of specific drugs or protocols is based on results of prior/ongoing

More information

Elements for a Public Summary. Overview of disease epidemiology

Elements for a Public Summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Acute myeloid leukemia (AML) Acute myeloid leukemia (AML) is a type of cancer characterized by the rapid growth of abnormal white

More information

Making the Most of Your Cancer Registry

Making the Most of Your Cancer Registry www.champsods.com Making the Most of Your Cancer Registry Presenter: Toni Hare, Vice President CHAMPS Oncology Data Services Picture of girl here December 11, 2009 Learning Objectives Upon completion of

More information

Leukemia. There are different types of leukemia and several treatment options for each type.

Leukemia. There are different types of leukemia and several treatment options for each type. Leukemia Introduction Leukemia is the name of a group of cancers of the blood cells. Hundreds of thousands of people worldwide are diagnosed with leukemia each year. There are different types of leukemia

More information

Competent Pain Management for Older Patients With Cancer

Competent Pain Management for Older Patients With Cancer Session length: 2 hours, 53 minutes Contact hours: 3.5 Pharmacology hours offered: 30 minutes 2005 ONS Virtual Institutes of Learning Evaluation Form Competent Pain Management for Older Patients With Cancer

More information

PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT

PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT Brandy Ficek, MD Medical Director of Quality of Life and Palliative Medicine Cancer Treatment Centers of America Rocky Mountain Blood Cancer

More information

Inaugural Guildford Supportive Care in Cancer Course

Inaugural Guildford Supportive Care in Cancer Course Inaugural Guildford Supportive Care in Cancer Course SUPPORTIVE CARE OVERVIEW Declan Walsh 4 th November 2015 A BRIEF HISTORY OF MEDICINE 2000 BC HERE, EAT THIS ROOT 1000 AD THAT ROOT IS HEATHEN, SAY THIS

More information

Acupuncture Needles. Overview. Gary Deng, MD,PhD. Traditional Theories. Acupuncture in Cancer Care: the USA Experience. History. Research Activities

Acupuncture Needles. Overview. Gary Deng, MD,PhD. Traditional Theories. Acupuncture in Cancer Care: the USA Experience. History. Research Activities , MD,PhD Acupuncture in Cancer Care: the USA Experience History Overview First ISS-ARTOI Conference on Integrative Oncology Fifth ARTOI International Congress Rome, Italy Nov 7, 2013, MD, PhD Integrative

More information

Hematology/Oncology Inpatient Rotation (Gold) PL2 Residents

Hematology/Oncology Inpatient Rotation (Gold) PL2 Residents PL2 Residents The Gold team at Comer Children s Hospital at the University of Chicago is comprised of 4 residents who care exclusively for inpatients suffering from hematologic and oncologic conditions.

More information

Neuroendocrine Tumors

Neuroendocrine Tumors Neuroendocrine Tumors Neuroendocrine tumors arise from cells that release a hormone in response to a signal from the nervous system. Neuro refers to the nervous system. Endocrine refers to the hormones.

More information

Integration of Palliative Care into Standard Oncology Care. Esther J. Luo MD Silicon Valley ONS June 2, 2018

Integration of Palliative Care into Standard Oncology Care. Esther J. Luo MD Silicon Valley ONS June 2, 2018 Integration of Palliative Care into Standard Oncology Care Esther J. Luo MD Silicon Valley ONS June 2, 2018 Objectives Become familiar with the literature illustrating the benefits of palliative care in

More information

Key Ouestions. to ask your medical oncology team after being diagnosed with breast cancer

Key Ouestions. to ask your medical oncology team after being diagnosed with breast cancer Key Ouestions to ask your medical oncology team after being diagnosed with breast cancer tips to make your visit with the physician a success: Bring this list of questions, a pen and paper to write down

More information

ALIMTA Administration and Education Guide

ALIMTA Administration and Education Guide ALIMTA Administration and Education Guide A comprehensive guide that includes customizable dosing handouts for patients and caregivers ALIMTA is indicated for the initial treatment of patients with locally

More information

Clinical Summary Note. Digital photographs. Echo Cardiogram. Mammogram. Angiogram. BMD scan Pet scan. Xray US

Clinical Summary Note. Digital photographs. Echo Cardiogram. Mammogram. Angiogram. BMD scan Pet scan. Xray US Ankle brachial inde Radiation Records (H) Eternal econsult Guidelines Updated 12/9/2016 Allergy Allergy Audiology Otorhinolaryngology Breast Clinic BRCA Mutation Family History Ca Breast Genetic Susceptibility

More information

Vinorelbine (Navelbine ) plus Capecitabine (Xeloda ) Cumbria, Northumberland, Tyne & Wear Area Team

Vinorelbine (Navelbine ) plus Capecitabine (Xeloda ) Cumbria, Northumberland, Tyne & Wear Area Team DRUG ADMINISTRATION SCHEDULE Day Drug Daily Dose Route Diluent Rate Day 1 Vinorelbine 60 to 80 mg/m 2 Oral N/A Stat Dose Days 1 to 14 Capecitabine 1000 mg/m 2 twice a day* Vinorelbine Capecitabine protocolcrp11b0024

More information

Oral Cancer: Diagnosis And Therapy

Oral Cancer: Diagnosis And Therapy Oral Cancer: Diagnosis And Therapy If you are looking for the book Oral Cancer: Diagnosis and Therapy in pdf form, in that case you come on to correct site. We present full release of this book in txt,

More information

Drug Resistant Tuberculosis Self-reporting of Drugrelated. During Treatment

Drug Resistant Tuberculosis Self-reporting of Drugrelated. During Treatment Drug Resistant Tuberculosis Self-reporting of Drugrelated Adverse Events During Treatment Introduction This information has been prepared for people with tuberculosis (TB) that is resistant to the commonly

More information

Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer

Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer Cetuximab with Chemotherapy as Treatment for Stage III Colon or Metastatic Colorectal Cancer Cetuximab with Chemotherapy (CT) as First-Line Treatment for Metastatic Colorectal Cancer (mcrc): Analysis of

More information

HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS. (Part Two) Presented live August 14, 2018

HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS. (Part Two) Presented live August 14, 2018 HIV/AIDS Today: What you need to know when providing services to individuals with HIV/AIDS (Part Two) Presented live August 14, 2018 Welcome Back! Technical Support 800-263-6317 Mary McCarty-Arias, M.A.,

More information

Past Chapter Summaries Educational Topics Summary

Past Chapter Summaries Educational Topics Summary Below is a comprehensive summary of all of the different Educational Topics our Local Chapters have presented and/or provided 2014 1. The most powerful force in nursing 2. Hope and meaning in life in adolescent

More information